Stocktoria
Akebia Therapeutics, Inc. AKBA
Akebia Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 11,638,484 | $11.9M | 4.38% |
| MILLENNIUM MANAGEMENT LLC | 2,384,713 | $3.3M | 0.9% |
| RENAISSANCE TECHNOLOGIES LLC | 1,833,128 | $2.5M | 0.69% |
| AQR CAPITAL MANAGEMENT LLC | 1,792,620 | $2.5M | 0.68% |
| CITADEL ADVISORS LLC | 1,726,367 | $2.4M | 0.65% |
| TWO SIGMA INVESTMENTS, LP | 1,297,801 | $1.8M | 0.49% |
| D. E. Shaw & Co., Inc. | 16,106 | $22,387 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.